- Filed
- Feb 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 13, 2025 | 31.41M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $107.37M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $223.05M |
| Current Assets | FY 2024 · Dec 31, 2023 | $230.81M |
| Total Assets | FY 2024 · Dec 31, 2023 | $433.14M |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 29.92M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $0 |
| Capex | FY 2024 · Dec 31, 2022 | $29.83M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$23.01M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $78.83M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$3.88 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$3.88 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $322.2M |
| Net Income | FY 2024 · Dec 31, 2022 | −$116.16M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$113.78M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $281.63M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $129.29M |
| Revenue | FY 2024 · Dec 31, 2022 | $410.92M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $279.52M |